Upcoming Webinar: Neurological Associations of COVID-19: Study results from COPING and CoCo-Neuro

15 October 2020 | 1 pm (London) | Register here

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present results from two studies from the UK and France. The COPING study assesses the impact of the novel coronavirus (COVID-19) pandemic on mental and neurological health, and how different factors associated with the virus are affecting the population. The CoCo-Neuro study characterises the neurological and psychiatric manifestations occurring in the context of Covid-19 infection and aims to improve clinical management, rehabilitation and follow-up.

Chair | Prof Tom Solomon, Liverpool Brain Infections Group

Speakers | Dr Cécile Delorme, Pitié-Salpêtrière Hospital, France: Neuropsychiatric manifestations in patients with Covid-19 : the Pitié-Salpêtrière experience

Professor Gerome Breen, King's College London, United Kingdom: TBC

Share the full poster



Click here to view this webinar in full screen. 

Webinar: Neurological disorders associated with COVID-19: Learnings from the current literature and 'mutant' responses to COVID-19

10/09/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will discuss what we can learn from the literature on neurological manifestations of COVID-19 and 'mutant' responses to COVID-19.



Click here to view this webinar in full screen. 

Neurological disorders associated with COVID-19: Neuropsychiatric and neurocognitive aspects in Australia and America

20/08/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review neuropsychiatric manifestations of COVID-19, and hear some preliminary results on the impact of COVID-19 on neurocognition and olfaction.



Click here to view this webinar in full screen. 

Neurological disorders associated with COVID-19: The Known and Unknown, and special focus on Alzheimer's dementia

02/07/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review complications of COVID-19 in patients with Alzheimer’s disease, as well as get some more insights into what’s known and unknow about Neurological Conditions in the Context of COVID-19.



Neurological disorders associated with COVID-19: Guillain-Barré Syndrome Cases and Patients on Immunomodulators

09/06/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. After a successful first webinar, we will now review the first few cases of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and discuss the management of patients on immunomodulators during the COVID-19 pandemic.

A workshop report is available here.



Click here to view this workshop in full screen. 


Neurological Disorders Associated with COVID-19

01/05/2020

The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. This webinar reviewed what’s known about neurological manifestations of SARS CoV-2 and related coronaviruses, consider the disease mechanisms and outline a framework for future investigative studies.

A workshop report is available here.